Relief Study

Assessing a new approach to migraine prevention

The Tricaprilin Relief study in migraine is based on a growing body of scientific evidence suggesting ketone bodies may help prevent migraine attacks. The exact way this happens is not yet clear, but could be due to addressing deficient brain glucose metabolism that is characteristic of numerous neurological conditions.

You can register your interest in the Relief study here.

Contact

Cerecin Pte. Ltd.
8 Shenton Way
#08-02
AXA Tower
Singapore 068811

Cerecin Inc

44 Cook Street
Suite 100-71
Denver, CO 80206
United States of America

Cerecin Pty Ltd

Level 13
41 Exhibition Street
Melbourne, VIC 3000
Australia